Release date- 12072016 - OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following company is verified for trading on the OTCQB Venture Market: Echo Therapeutics, Inc. (OTCQB: ECTE) - Echo Therapeutics is a medical device company with expertise in advanced skin permeation technology.
The company develops a non-invasive, wireless continuous glucose monitoring (CGM) system for initial use in the diabetes outpatient market. They believe other significant opportunities exist in the wearable-health consumer market and the hospital setting. The transdermal skin preparation component of their CGM System allows for enhanced skin permeation that will enable extraction of analytes such as glucose, enhanced delivery of topical pharmaceuticals and other applications.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX Best Market, the OTCQB Venture Market, and the Pink Open Market for 10,000 U.S. and global securities. Through OTC Link ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
Tel: +1 212.896.4400
Fax: +1 212.868.3848
(c) 2016 Electronic News Publishing -, source ENP Newswire